0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query globaldata dong wha pharma co ltd 000020 financial strategic swot analysis review 0.Your search for "" gave back 1496072 results.
The global Pulmonary Embolism Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Suzuken Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Suzuken Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source...
MarketLine
December 2022
Price: USD 175.00
Irritable Bowel Syndrome - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
May 2018
Price: USD 2,000.00
Ventilator Associated Pneumonia (VAP) (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical...
Catalog:
Global Markets Direct
March 2021
Price: USD 2,000.00
Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
January 2023
Price: USD 175.00
The global Medicinal and Food Homologous Health Product market size was valued at US$ million in 2022. With growing demand in downstream market and...
Catalog:
LPI
August 2023
Price: USD 3,660.00
Atrial Fibrillation - Pipeline Review, H1 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation - Pipeline...
Catalog:
Global Markets Direct
April 2019
Price: USD 2,000.00
Shionogi & Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Shionogi & Co., Ltd - Strategy, SWOT and Corporate Finance Report,...
MarketLine
March 2022
Price: USD 175.00
Kyowa Kirin Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary Kyowa Kirin Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
March 2022
Price: USD 175.00
Benign Prostatic Hyperplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets...
Catalog:
Global Markets Direct
October 2022
Price: USD 2,000.00
Yifan Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yifan Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance...
MarketLine
June 2022
Price: USD 175.00
Hepatitis B (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
September 2021
Price: USD 2,500.00
Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report...
MarketLine
January 2021
Price: USD 175.00
Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) Drugs in Development by Therapy Areas...
Catalog:
Global Markets Direct
April 2022
Price: USD 3,500.00
Anemia in Chronic Kidney Disease (Renal Anemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,000.00
